board WHOcte. Soft tissue and bone tumours. 5th ed. World Health Organization classification of tumours. World Health Organization. International Agency for Research on Cancer; 2020.
Nagano A, Urakawa H, Tanaka K, Ozaki T. Current management of giant-cell tumor of bone in the denosumab era. Jpn J Clin Oncol. 2022;52(5):411–6. https://doi.org/10.1093/jjco/hyac018.
Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am. 2006;37(1):35–51. https://doi.org/10.1016/j.ocl.2005.08.005.
Rekhi B, Dave V. Giant cell tumor of bone: an update, including spectrum of pathological features, pathogenesis, molecular profile and the differential diagnoses. Histol Histopathol. 2023;38(2):139–53. https://doi.org/10.14670/hh-18-486.
Article CAS PubMed Google Scholar
Basu Mallick A, Chawla SP. Giant cell tumor of bone: an update. Curr Oncol Rep. 2021;23(5):51. https://doi.org/10.1007/s11912-021-01047-5.
Article CAS PubMed Google Scholar
Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, et al. Establishment and characterization of NCC-GCTB1-C1: a novel patient-derived cancer cell line of giant cell tumor of bone. Hum Cell. 2020;33(4):1321–8. https://doi.org/10.1007/s13577-020-00415-w.
Article CAS PubMed Google Scholar
Yamamoto H, Ishihara S, Toda Y, Oda Y. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology. Med Mol Morphol. 2020;53(1):1–6. https://doi.org/10.1007/s00795-019-00238-1.
Article CAS PubMed Google Scholar
Taylor EL, Westendorf JJ. Histone mutations and bone cancers. Adv Exp Med Biol. 2021;1283:53–62. https://doi.org/10.1007/978-981-15-8104-5_4.
Article CAS PubMed Google Scholar
Yang L, Zhang H, Zhang X, Tang Y, Wu Z, Wang Y, et al. Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): analysis of 21 cases. Ann Diagn Pathol. 2022;57: 151882. https://doi.org/10.1016/j.anndiagpath.2021.151882.
Li H, Gao J, Gao Y, Lin N, Zheng M, Ye Z. Denosumab in giant cell tumor of bone: current status and pitfalls. Front Oncol. 2020;10: 580605. https://doi.org/10.3389/fonc.2020.580605.
Article PubMed PubMed Central Google Scholar
Lin X, Liu J, Xu M. The prognosis of giant cell tumor of bone and the vital risk factors that affect its postoperative recurrence: a meta-analysis. Transl Cancer Res. 2021;10(4):1712–22. https://doi.org/10.21037/tcr-20-3100.
Article PubMed PubMed Central Google Scholar
Yang Y, Huang Z, Niu X, Xu H, Li Y, Liu W. Clinical characteristics and risk factors analysis of lung metastasis of benign giant cell tumor of bone. J Bone Oncol. 2017;7:23–8. https://doi.org/10.1016/j.jbo.2017.04.001.
Article PubMed PubMed Central Google Scholar
Palmerini E, Picci P, Reichardt P, Downey G. Malignancy in giant cell tumor of bone: a review of the literature. Technol Cancer Res Treat. 2019;18:1533033819840000. https://doi.org/10.1177/1533033819840000.
Muheremu A, Niu X. Pulmonary metastasis of giant cell tumor of bones. World J Surg Oncol. 2014;12:261. https://doi.org/10.1186/1477-7819-12-261.
Article PubMed PubMed Central Google Scholar
Aponte-Tinao LA, Piuzzi NS, Roitman P, Farfalli GL. A High-grade sarcoma arising in a patient with recurrent benign giant cell tumor of the proximal tibia while receiving treatment with denosumab. Clin Orthop Relat Res. 2015;473(9):3050–5. https://doi.org/10.1007/s11999-015-4249-2.
Article PubMed PubMed Central Google Scholar
Kondo T. Current status and future outlook for patient-derived cancer models from a rare cancer research perspective. Cancer Sci. 2021;112(3):953–61. https://doi.org/10.1111/cas.14669.
Article CAS PubMed PubMed Central Google Scholar
Hattori E, Oyama R, Kondo T. Systematic review of the current status of human sarcoma cell lines. Cells. 2019;8(2):157. https://doi.org/10.3390/cells8020157.
Article CAS PubMed PubMed Central Google Scholar
Goodspeed A, Heiser LM, Gray JW, Costello JC. Tumor-derived cell lines as molecular models of cancer pharmacogenomics. Mol Cancer Res. 2016;14(1):3–13. https://doi.org/10.1158/1541-7786.Mcr-15-0189.
Article CAS PubMed Google Scholar
Bairoch A. The cellosaurus, a cell-line knowledge resource. J Biomol Tech. 2018;29(2):25–38. https://doi.org/10.7171/jbt.18-2902-002.
Article PubMed PubMed Central Google Scholar
Drexler HG, Dirks WG, MacLeod RA, Uphoff CC. False and mycoplasma-contaminated leukemia-lymphoma cell lines: time for a reappraisal. Int J Cancer. 2017;140(5):1209–14. https://doi.org/10.1002/ijc.30530.
Article CAS PubMed Google Scholar
Ono T, Noguchi R, Yoshimatsu Y, Tsuchiya R, Sin Y, Nakagawa R, et al. Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone. Hum Cell. 2022;35(1):392–9. https://doi.org/10.1007/s13577-021-00639-4.
Article CAS PubMed Google Scholar
Ono T, Noguchi R, Yoshimatsu Y, Sin Y, Tsuchiya R, Akiyama T, et al. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone. Hum Cell. 2023;36(5):1804–12. https://doi.org/10.1007/s13577-023-00928-0.
Article CAS PubMed Google Scholar
Yoshimatsu Y, Noguchi R, Tsuchiya R, Ono T, Sin Y, Akane S, et al. Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone. Hum Cell. 2021;34(6):1899–910. https://doi.org/10.1007/s13577-021-00579-z.
Article CAS PubMed Google Scholar
Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, et al. Establishment and characterization of NCC-GCTB5-C1: a novel cell line of giant cell tumor of bone. Hum Cell. 2022;35(5):1621–9. https://doi.org/10.1007/s13577-022-00724-2.
Article CAS PubMed Google Scholar
Gonçalves E, Poulos RC, Cai Z, Barthorpe S, Manda SS, Lucas N, et al. Pan-cancer proteomic map of 949 human cell lines. Cancer Cell. 2022;40(8):835-49.e8. https://doi.org/10.1016/j.ccell.2022.06.010.
Article CAS PubMed PubMed Central Google Scholar
Kinker GS, Greenwald AC, Tal R, Orlova Z, Cuoco MS, McFarland JM, et al. Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. Nat Genet. 2020;52(11):1208–18. https://doi.org/10.1038/s41588-020-00726-6.
Article CAS PubMed PubMed Central Google Scholar
Jiang G, Zhang S, Yazdanparast A, Li M, Pawar AV, Liu Y, et al. Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer. BMC Genomics. 2016;17(Suppl 7):525. https://doi.org/10.1186/s12864-016-2911-z.
Article CAS PubMed PubMed Central Google Scholar
Karpik M. Giant cell tumor (tumor gigantocellularis, osteoclastoma)—epidemiology, diagnosis, treatment. Ortop Traumatol Rehabil. 2010;12(3):207–15.
MathSciNet PubMed Google Scholar
Lim J, Park JH, Baude A, Yoo Y, Lee YK, Schmidt CR, et al. The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing. Sci Rep. 2017;7(1):13459. https://doi.org/10.1038/s41598-017-13887-y.
Article ADS CAS PubMed PubMed Central Google Scholar
Wang Y, Jeon H. 3D cell cultures toward quantitative high-throughput drug screening. Trends Pharmacol Sci. 2022;43(7):569–81. https://doi.org/10.1016/j.tips.2022.03.014.
Article CAS PubMed Google Scholar
Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 2009;4(3):309–24. https://doi.org/10.1038/nprot.2008.226.
Article CAS PubMed Google Scholar
Shimony S, Horowitz N, Ribakovsky E, Rozovski U, Avigdor A, Zloto K, et al. Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: real-life data from a national multicenter observational study. Hematol Oncol. 2019;37(5):569–77. https://doi.org/10.1002/hon.2691.
Article CAS PubMed Google Scholar
Venneker S, van Eenige R, Kruisselbrink AB, Palubeckaitė I, Taliento AE, Briaire-de Bruijn IH, et al. Histone deacetylase inhibitors as a therapeutic strategy to eliminate neoplastic “stromal” cells from giant cell tumors of bone. Cancers (Basel). 2022;14(19):4708. https://doi.org/10.3390/cancers14194708.
Article CAS PubMed Google Scholar
Yafei J, Haoran M, Wenyan J, Linghang X, Kai T, Gangyang W, et al. Personalized medicine modality based on patient-derived xenografts from a malignant transformed GCTB harboring H3F3A G34W mutation. J Orthop Translat. 2021;29:106–12. https://doi.org/10.1016/j.jot.2021.04.004.
留言 (0)